IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 73 filers reported holding IMMUNIC INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $156,136 | -93.4% | 106,215 | -88.8% | 0.00% | -100.0% |
Q2 2023 | $2,373,950 | +125905.8% | 945,797 | -25.2% | 0.00% | 0.0% |
Q1 2023 | $1,884 | +84.0% | 1,264,623 | +72.9% | 0.00% | 0.0% |
Q4 2022 | $1,024 | -100.0% | 731,544 | -39.5% | 0.00% | -50.0% |
Q3 2022 | $3,819,000 | -25.1% | 1,208,494 | -17.8% | 0.00% | -33.3% |
Q2 2022 | $5,100,000 | -35.5% | 1,469,654 | +110.1% | 0.00% | -25.0% |
Q1 2022 | $7,906,000 | +44.7% | 699,563 | +22.6% | 0.00% | +33.3% |
Q4 2021 | $5,462,000 | +24.6% | 570,701 | +15.3% | 0.00% | 0.0% |
Q3 2021 | $4,382,000 | +49.2% | 495,171 | +106.7% | 0.00% | +50.0% |
Q2 2021 | $2,937,000 | +15.6% | 239,556 | +50.4% | 0.00% | 0.0% |
Q1 2021 | $2,540,000 | -22.0% | 159,323 | -25.2% | 0.00% | 0.0% |
Q4 2020 | $3,256,000 | -47.3% | 212,917 | -36.0% | 0.00% | -75.0% |
Q3 2020 | $6,177,000 | +10026.2% | 332,613 | +3142.2% | 0.01% | – |
Q1 2020 | $61,000 | -45.0% | 10,259 | -10.5% | 0.00% | – |
Q4 2019 | $111,000 | -7.5% | 11,463 | -4.0% | 0.00% | – |
Q3 2019 | $120,000 | -64.9% | 11,937 | -60.0% | 0.00% | -100.0% |
Q2 2019 | $342,000 | – | 29,809 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
Logos Global Management LP | 421,184 | $619,140 | 0.08% |
Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |